1,25-dihydroxyvitamin d3 attenuates of expression of experimental murine lupus of MRL/1 mice

Autoimmunity

Volumn 12, Issue 2, 1992, Pages 143-148

  Lemire, Jacques M ^a   Ince, Ann ^a   Takashima, Masayoshi ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antinuclear antibodies; Immunosuppression; Murine lupus; Proteinuria; Skin lesions

Indexed keywords

CALCITRIOL; CREATININE; DNA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HYPERCALCEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHADENOPATHY; MOUSE; NONHUMAN; PROTEINURIA; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMAL; ANTIBODIES, ANTINUCLEAR; CALCITRIOL; CALCIUM; DISEASE MODELS, ANIMAL; FEMALE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED STRAINS; PROTEINURIA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026772395     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939209150321     Document Type: Article

References (21)

1. la,25-Dihydroxy-vitamin D, suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells
2. Interactions of 1,25-dihydroxyvitamin D3 and the immune system
3. The immunobiology of vitamin D
4. 3
5. 1,25-Dihydroxyvitamin D3 suppresses human helper/inducer lymphocyte activity in vitro
6. 1,25-Dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes
7. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis
8. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
9. Distribution of lymphocytes identified by surface markers in murine strains with SLE-like syndromes
10. The antibody response of normal mice to immunization with single-stranded DNA of various species origin
11. Differentiation of a human monocytic cell line by 1,25-Dihydroxyvitamin D3 (calcitriol): A morphologic, phenotypic, and functional analysis
12. A novel approach for the evaluation and treatment of psoriasis
13. 3. A review of our experience
14. 3 prolongs survival time of mice inoculated with myeloid leukemia cells
15. Characterization of cutaneous infiltrates in MRL/Ipr mice monitored from onset to the full development of lupus erythematosus-Iike skin lesions
16. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis
17. 3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice
18. 1,25-Dihydroxy-16-ene-23-yne-vitamin D, prolongs survival time of leukemic mice
19. 3 énhances the generation of non-specific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR
20. CS-A therapy in MRL-lpr/lpr mice; amelioration of immunopathology despite autoantibody production